z-logo
open-access-imgOpen Access
Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
Author(s) -
Christian Ciolfi,
Alvise Sernicola,
Mauro Alaibac
Publication year - 2022
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s350756
Subject(s) - rituximab , medicine , pemphigus vulgaris , tolerability , pemphigus , adverse effect , adjuvant , cd20 , dosing , immunology , lymphoma , oncology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom